1Uekado Y, Hirano A, Shinka T, et al. The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report.Cancer Chemother Pharmacol, 1994, 35: 65- 68.
4Rajala P, Liukkonen T, Raitanen M, et al. Transurethral resecrion with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer:, a prospeetive randomized multicenter study-Finnbladder Ⅲ. J Urol,1999, 161:1133-1135.,
5Saika T, Tsushima T, Nasu Y, et al. Tissue concentration of intravesically instilled (2'' R)-4'-o-tetrahydro- pyranyl-adriamycin or adriamycin in superficial bladder cancer[J]. Nippon Hinyokika Gakkai Zasshi, 1993, 84 (7) : 1206- 1210.
6Akagashi K, Tanda H, Kato S. Recurrence pattern for superficial bladder cancer[J]. Int J Urol, 2006, 13(6) :686-691.
7Yumura Y, Takase K, Kato Y, et al. The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence[J].Hinyokika Kiyo, 2004, 50 (3): 171 -176.
8Yamamoto Y, Nasu Y, Saika T, et al. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer[J]. BJU Int, 2000,86(7) :802-804.
9Aikawa K, Irisawa C, Muraki O, et al. Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group[J]. Gan To Kagaku Ryoho, 1992,19(4):509-513.
10Kuroda K, Ishii N, Fukasawa K, et al. Short-term intravesical instillation of pirarubicin (THP) in prophy lactic treatment after transurethral resection of superficial bladder tumor[J].Hinyokika Kiyo, 1998,44(8) 547-552.
